APA
Schaer D. A., Beckmann R. P., Dempsey J. A., Huber L., Forest A., Amaladas N., Li Y., Wang Y. C., Rasmussen E. R., Chin D., Capen A., Carpenito C., Staschke K. A., Chung L. A., Litchfield L. M., Merzoug F. F., Gong X., Iversen P. W., Buchanan S., de Dios A., Novosiadly R. D. & Kalos M. (20190909). The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade. : Cell reports.
Chicago
Schaer David A, Beckmann Richard P, Dempsey Jack A, Huber Lysiane, Forest Amelie, Amaladas Nelusha, Li Yanxia, Wang Ying Cindy, Rasmussen Erik R, Chin Darin, Capen Andrew, Carpenito Carmine, Staschke Kirk A, Chung Linda A, Litchfield Lacey M, Merzoug Farhana F, Gong Xueqian, Iversen Philip W, Buchanan Sean, de Dios Alfonso, Novosiadly Ruslan D and Kalos Michael. 20190909. The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade. : Cell reports.
Harvard
Schaer D. A., Beckmann R. P., Dempsey J. A., Huber L., Forest A., Amaladas N., Li Y., Wang Y. C., Rasmussen E. R., Chin D., Capen A., Carpenito C., Staschke K. A., Chung L. A., Litchfield L. M., Merzoug F. F., Gong X., Iversen P. W., Buchanan S., de Dios A., Novosiadly R. D. and Kalos M. (20190909). The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade. : Cell reports.
MLA
Schaer David A, Beckmann Richard P, Dempsey Jack A, Huber Lysiane, Forest Amelie, Amaladas Nelusha, Li Yanxia, Wang Ying Cindy, Rasmussen Erik R, Chin Darin, Capen Andrew, Carpenito Carmine, Staschke Kirk A, Chung Linda A, Litchfield Lacey M, Merzoug Farhana F, Gong Xueqian, Iversen Philip W, Buchanan Sean, de Dios Alfonso, Novosiadly Ruslan D and Kalos Michael. The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade. : Cell reports. 20190909.